COMT and Parkinson disease: Entacapone is a COMT inhibitor that improves motor symptoms and quality of life in Parkinson's disease patients by inhibiting COMT enzyme activity, prolonging the half‐life of levodopa, and enhancing its action time in the central nervous system [69].